Literature DB >> 16043331

Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: an exploratory approach.

Astrid Zobel1, Alexius Joe, Nikolaus Freymann, Hans Clusmann, Johannes Schramm, Michael Reinhardt, Hans-Jürgen Biersack, Wolfgang Maier, Karl Broich.   

Abstract

Abnormalities in regional cerebral blood flow (rCBF) have been reported to characterize depressive episodes; they are at least partly reversed by antidepressant treatment. Treatment-specific as well as response-related changes in rCBF have been reported. We explored the changes in rCBF induced by vagus nerve stimulation (VNS), a recently proposed antidepressant strategy, by application of single photon emission-computed tomography with (99m)Tc-hexamethyl-propylene amine oxime in otherwise treatment-refractory patients. Both region-of-interest (ROI) and statistical parametric mapping (SPM) analytic approaches were used. Decreases of rCBF in the amygdala, left hippocampus, left subgenual cingulate cortex, left and right ventral anterior cingulum, right thalamus and brain stem were observed; the only increase of rCBF was found by SPM analysis in the middle frontal gyrus. This pattern shares features with changes of rCBF previously associated with the administration of selective serotonin reuptake inhibitors. Similarities to other brain-stimulation strategies in antidepressant treatment were less pronounced.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043331     DOI: 10.1016/j.pscychresns.2005.02.010

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  37 in total

1.  Comparison of ΔFosB immunoreactivity induced by vagal nerve stimulation with that caused by pharmacologically diverse antidepressants.

Authors:  Havan Furmaga; Mohona Sadhu; Alan Frazer
Journal:  J Pharmacol Exp Ther       Date:  2012-01-27       Impact factor: 4.030

2.  BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation.

Authors:  T Kraus; K Hösl; O Kiess; A Schanze; J Kornhuber; C Forster
Journal:  J Neural Transm (Vienna)       Date:  2007-06-14       Impact factor: 3.575

3.  Brain blood-flow change with acute vagus nerve stimulation in treatment-refractory major depressive disorder.

Authors:  Charles R Conway; Yvette I Sheline; John T Chibnall; Richard D Bucholz; Joseph L Price; Sunil Gangwani; Mark A Mintun
Journal:  Brain Stimul       Date:  2011-04-03       Impact factor: 8.955

4.  Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: a potential marker for response?

Authors:  Charles R Conway; John T Chibnall; Sunil Gangwani; Mark A Mintun; Joseph L Price; Tamara Hershey; Luis A Giuffra; Richard D Bucholz; Jon J Christensen; Yvette I Sheline
Journal:  J Affect Disord       Date:  2012-03-05       Impact factor: 4.839

5.  Emotional and autonomic consequences of spinal cord injury explored using functional brain imaging.

Authors:  Alessia Nicotra; Hugo D Critchley; Christopher J Mathias; Raymond J Dolan
Journal:  Brain       Date:  2005-12-05       Impact factor: 13.501

Review 6.  Electrical stimulation of cranial nerves in cognition and disease.

Authors:  Devin Adair; Dennis Truong; Zeinab Esmaeilpour; Nigel Gebodh; Helen Borges; Libby Ho; J Douglas Bremner; Bashar W Badran; Vitaly Napadow; Vincent P Clark; Marom Bikson
Journal:  Brain Stimul       Date:  2020-02-23       Impact factor: 8.955

Review 7.  Vagus nerve stimulation for epilepsy and depression.

Authors:  Andrew H Milby; Casey H Halpern; Gordon H Baltuch
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

8.  Altered brain network modules induce helplessness in major depressive disorder.

Authors:  Daihui Peng; Feng Shi; Ting Shen; Ziwen Peng; Chen Zhang; Xiaohua Liu; Meihui Qiu; Jun Liu; Kaida Jiang; Yiru Fang; Dinggang Shen
Journal:  J Affect Disord       Date:  2014-07-01       Impact factor: 4.839

Review 9.  Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic.

Authors:  Kerry J Ressler; Helen S Mayberg
Journal:  Nat Neurosci       Date:  2007-09       Impact factor: 24.884

10.  Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glucose metabolism.

Authors:  José V Pardo; Sohail A Sheikh; Graeme C Schwindt; Joel T Lee; Michael A Kuskowski; Christa Surerus; Scott M Lewis; Faruk S Abuzzahab; David E Adson; Barry R Rittberg
Journal:  Neuroimage       Date:  2008-05-15       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.